Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

CDP New Grants for Fiscal Year 2003

R43 Award by CDP in Response to PA 00-018, Bioengineering Nanotechnology Initiative

Daniels, R Hugh, PhD
Nanowire DNA Hybridization Sensor
Nanosys, Inc, Palo Alto, CA

R21 Award by CDP in Response to PA 01-010, Exploratory Studies in Cancer Detection, Prognosis and Prediction

This Program Announcement replaces and supersedes two prior Program Announcements, PA-98-022 (Exploratory Studies in Cancer Diagnostics) and PA-98-042 (Exploratory Grants for Correlative Laboratory Studies and Clinical Trials).

Bale, Allen E, MD
Molecular Classification of Basal Cell Carcinomas
Yale University, New Haven, CT

Bueno, Raphael, MD
Gene Ratios for Lung Cancer Detection and Prognosis
Brigham and Women's Hospital, Boston, MA

Cheung, Irene Y, ScD
Molecular Detection of Occult Neuroblastoma
Sloan-Kettering Institute for Cancer Research, New York, NY

Clelland, Catherine L Taylor, PhD
Prostate Tumor Diagnosis: Blood Cell Multigene Signatures
Mount Sinai School of Medicine of NYU, New York, NY

Clelland, Catherine L Taylor, PhD
Breast Cancer Diagnosis: Blood-Cell Multigene Signatures
Mount Sinai School of Medicine of NYU, New York, NY

Kibel, Adam S, MD
Genetic Risk Profiling In Metastatic Prostate Carcinoma
Washington University, St. Louis, MO

Laird-Offringa, Ite A, PhD
Lung Cancer Diagnosis Using DNA Methylation Signatures
University of Southern California, Los Angeles, CA

Larson, Richard S, MD, PhD
T-All Stromal Cell Interaction and Patient Outcome
University of New Mexico Albuquerque, Albuquerque, NM

Press, Richard D, MD, PhD
Bcr-abl RNA Levels to Monitor STI571 Leukemia Therapy
Oregon Health & Science University, Portland, OR

Rimm, David L, MD
AQUA: A New Quantitative in situ Proteomic Assay
Yale University, New Haven, CT

Vundavalli, Murty V, PhD
Molecular Genetics of Cervical Cancer Progression
Columbia University Health Sciences, New York, NY

Yarbrough, Wendell G, MD
Gene Expression as Predictor of Metastasis in HNSCC
Vanderbilt University, Nashville, TN

Zeiger, Martha A, MD
Microarray Analysis of Thyroid Neoplasm
Johns Hopkins University, Baltimore, MD

R01 and R21 Grants Awarded by CDP in Response to PA 01-015, Correlative Studies using Specimens from Multi-Institutional Prevention and Treatment Trials

Petersdorf, Effie W, MD
SNPs in Lung Cancer Risk and Therapeutic Response
Fred Hutchinson Cancer Research Center, Seattle, WA

R21/R33 and R33 Grants Awarded by CDP in Response to PAR 01-061, Phased Application Awards in Cancer Prognosis and Prediction

Caldwell, Charles W, MD, PhD
Epigenetic Signature of Non-Hodgkin's Lymphomas
University of Missouri Columbia, Columbia, MO

Goodfellow, Paul J, PhD
rDNA Methylation and Prognosis in Endometrial Cancers
Washington University, St. Louis, MO

Hoon, Dave SB, PhD
DNA Markers as Surrogates: Melanoma Patient Response
John Wayne Cancer Institute, Santa Monica, CA

Huang, Sui, MD, PhD
The Perinucleolar Compartment as Breast Cancer Marker
Northwestern University, Evanston, IL

Mok, Samuel C, PhD
Prognostic Markers for Ovarian Cancer
Brigham and Women's Hospital, Boston, MA

Tainsky, Michael A, PhD
Markers for the Early Detection of Ovarian Cancer
Wayne State University, Detroit, MI

R43 Grants Awarded by CDP in Response to PAR 01-062, Cancer Prognosis and Prediction: SBIR/STTR Initiative

Allen, Antonette C, MS
Multimarker Detection of Breast Metastases in PET Nodes
BRT Laboratories, Inc., Baltimore, MD

Murphy, Elizabeth J, MD, PhD
Kinetic Biomarker for CCL Prognosis
KineMed, Inc., Emeryville, CA

R21/R33 Grants Awarded by CDP in Response to PAR 01-104, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award

This Program Announcement (PA) replaces PAR-99-100, which was publishedin the NIH Guide on May 14, 1999.

Ferrari, Mauro, PhD
Nanomechanical Method for Molecular Analysis of Cancer
Ohio State University, Columbus, OH

Golovlev, Val V, PhD
Magnetically Readable Microarray
Sci-Tec, Inc., Knoxville, TN

Goodlett, David R, PhD
Parallel Peptide Tandem Mass Spectromtry (MS)
Institute for Systems Biology, Seattle, WA

Kron, Stephen J, MD, PhD
BCR-ABL Kinase Assays for STI571 Sensitivity Reponse
University of Chicago, Chicago, IL

Majumdar, Arunava, PhD
Nanocapillary Electrophoresis for Profiling Cancer
University of California Berkeley, Berkeley, CA

Taylor, Clive R, MD, PhD
Retrieval of DNA, RNA, and Protein from Archival Tissue
University of Southern California, Los Angeles, CA

R43 Grants Awarded by CDP in Response to PAR 01-105, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR

This Program Announcement (PA) replaces PAR-99-101, which was publishedin the NIH Guide on May 14, 1999.

Krizman, David B, PhD
Protein Arrays for Molecular Analysis of Cancer Tissue
Expression Pathology, Inc, Rockvile, MD

Nedelkov, Dobrin, PhD
Affinity-Based Mass Spectrometry Protein Assays
Intrinsic Bioprobes, Inc, Tempe, AZ

Shen, Li, PhD
An ID-Tag Protein Profiling Array for the Molecular Characterization of Cancer
SuperArray Bioscience Corporation, Frederick, MD

Zebala, John A, MD, PhD
Instrumentation for High-Resolution Analysis of Cancer
Syntrix Biosystems, Inc, Redmond, WA

Zebala, John A, MD, PhD
Artificial Antibody Mimetics
Syntrix Biosystems, Inc, Redmond, WA

R21/R33 and R33 Grants Awarded by CDP in Response to PAR 01-106, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award

This Program Announcement (PA) replaces PAR-99-102, which was publishedin the NIH Guide on May 14, 1999.

Barron, Annelise E, PhD
Fast Mutation Detection by Tandem SSCP/HA on Microchips
Northwestern University, Evanston, IL

Lizardi, Paul M, PhD
Genetic Analysis of Amplified Genomic DNA Archives
Yale University, New Haven, CT

Soper, Steven A, PhD
Microsampling Unit for Capturing Low Abundant Cells
Louisiana State Univ A&M Col Baton Rouge, Baton Rouge, LA

R43 Grants Awarded by CDP in Response to PAR 01-107, Applications of Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR

This Program Announcement (PA) replaces PAR-99-103, which was publishedin the NIH Guide on May 14, 1999.

Agnew, Brian J, PhD
Proteomic Analyses of Breast Cancer Refractoriness
Molecular Probes, Inc, Eugene, OR

Chen, Wen-Tien, PhD
Gene Expression of Viable Ovarian Cancer Cells
Vitatex, Inc, Stony Brook, NY

Ching, Jesus, PhD
Automated RNA Isolation and RT-PCR for Cancer Detection
Cepheid, Sunnyvale, CA